With the aim to devise a long-term gene therapy protocol survival, unscheduled DNA synthesis and recovery of RNA for skin cancers in individuals affected by the inherited synthesis, and Western blots. The results show that the autosomal recessive xeroderma pigmentosum, we transrecombinant retroviruses are highly efficient vectors to ferred the human DNA repair XPA, XPB/ERCC3 and XPC transfer and stably express the human DNA repair genes cDNAs, by using the recombinant retroviral vector LXSN, in XP cells and correct the defect of DNA repair of group into primary and immortalized fibroblasts obtained from two A, B and C. With our previous results with XPD/ERCC2, XP-A, one XP-B (associated with Cockayne's syndrome) the present work extends further promising issues for the and two XP-C patients. After transduction, the complete gene therapy strategy for most patients suffering from this correction of DNA repair deficiency and functional cancer-prone syndrome. expression of the transgenes were monitored by UV
Introduction
ERCC4, ERCC5 and ERCC6 were found to be identical to Xeroderma pigmentosum (XP) is a rare human autosomal the genes involved in xeroderma pigmentosum groups recessive disease characterized clinically by hypersensi-D, B, F and G and Cockayne's syndrome group B. [13] [14] [15] [16] [17] A tivity to ultraviolet (UV) rays, high predisposition for multiprotein complex of approximately 30 gene products developing skin cancers (basal and squamous cell carciis involved in the NER pathway, whereby DNA damage nomas and melanomas) on sunlight exposed areas, 1 and is eliminated and replaced by excision-resynthesis, as has in some cases, neurological disorders. [2] [3] [4] XP has a worldbeen demonstrated by using the in vitro repair assay with wide distribution, with the incidence varying from about purified factors. 18 Mutations in one of these genes result 1:250 000 in Europe and the USA to as high as 1:40 000 in UV-sensitive disorders: skin cancer-prone XP and in Japan, North Africa and in Egypt. [5] [6] [7] The cellular other clinically different syndromes, such as skin cancerphenotype of XP has increased sensitivity to killing folfree trichothiodystrophy (TTD) and Cockayne syndrome lowing exposure to a wide variety of DNA damaging (CS), and association of XP with CS. agents, including UV radiation and UV mimetic chemiThe NER process is evolutionarily conserved in eukarcals. The observation that skin fibroblasts in culture from yotes, and homologue genes of human repair genes have an XP patient are unable to carry out nucleotide excision been identified in many organisms, namely in Saccharorepair (NER) following exposure to UV established the myces cerevisiae. 19 In humans, the proteins encoded by relationship between DNA repair defect and skin photosome of these genes are components of the multiprotein carcinogenesis in man. 1, 8, 9 TFIIH complex involved with RNA polymerase II in The systematic complementation of DNA repair basal transcription. Consistently, the yeast homologues of defects by cell fusion assay has led to the identification some of these proteins, the Rad25 and Rad3 (homologue of seven genetic groups in this disease, designated XP-A to ERCC3/XPB and ERCC2/XPD, respectively), have also to -G, 7 and a variant group, designated XP-V, exhibiting been identified as components of TFIIH. Therefore, these normal NER. 10 So far, most of the relevant human genes, proteins play a dual role in both NER and transcripsuch as XPA, XPB, XPC, XPD, XPF and XPG, have been tion. [20] [21] [22] cloned and mapped to different specific chromosomal The mean age of XP patients at the time of diagnosis locations. A further source of NER defective mutants is a is 3 years while the mean age of onset of first skin cancer set of 11 complementation groups of UV-sensitive rodent is 8 years. There is an approximate 30-40 year reduction cells. The human genes that correct the rodent cell phenoin survival. Many patients have died of neoplasms. 2 So type are designated ERCC (excision repair crossfar, there is no effective long-term treatment available for XP patients. Some protective measures can be taken to keep patients from exposure to sunlight, 23 and skin grafts from the same patient were performed to resurface the therapeutical protocol is efficient only in the short term, complementation groups, transduced and untransduced cells were analyzed for: since skin grafts are still genetically DNA repair defective and thus cancer prone. 24 The genetic correction of XP (1 Figure 2a and genes into cells derived from XP patients. 25, 26 Several b, respectively), XPCS2BASV (XP-B group, Figure 2c ) retroviral constructions are efficient tools for gene delivand XP16VI and XP30VI (XP-C group, Figure 2d ). ery and stable expression in many human cells and After transduction with the retrovirus harboring the tissues. 27 We recently devised the first retrovirus harborappropriate cDNA, all cell lines recovered wild-type ing a DNA repair gene (XPD/ERCC2), which efficiently UV resistance, since their survival curves were indistransduces several DNA repair-deficient human primary tinguishable from those of 198VI and MRC5V1 lines skin fibroblasts belonging to the complementation XP-D (Figure 2a-d) . When XP cells were cross-transduced group and fully corrects their DNA repair defect. 28, 29 In with retrovirus containing other cDNA than that order to validate this investigation with other genes involved in the genetic group, no correction of UV involved in XP disease and to dispose of basic tools for survival was observed (Figure 2a, c H-thymidine fibroblasts from two XP-A, one XP-B and two XP-C was measured after UV irradiation ( Figure 3 ). Both patients.
XP12ROSV and XP24VI exhibited reduced UDS levels, (5.4 ± 2 and 2.9 ± 1.1 grains per nucleus) at 15 J/m 2 , corresponding to 26 and 14.6% of normal levels,
Results
respectively. After transduction of the same cells with LXPASN, the UDS levels were restored to almost norEstablishment of recombinant retrovirus The LXPASN, LXPBSN and LXPCSN vectors were mal levels (18 ± 4 and 17 ± 5 grains per nucleus, respectively, corresponding to 85% of the normal levderived from the Moloney murine leukemia virus (MoMLV)-based retroviral vector LXSN and were proels, Figure 3a and b). XPCS2BASV cells showed virtually a complete defect of DNA repair with all three duced after insertion into the polylinker of XPA, XPB and XPC cDNAs as described in Materials and methods and depicted in Figure 1 . The expression of the introduced sequence was under the control of the LTR promoter and the polyadenylation signal. After transfection of ⌿CRE packaging cells, subsequent infection of ⌿CRIP cells and selection with G418, 30-32 among all clones tested, the best virus titers obtained were 3 × 10 5 c.f.u./ml for LXPASN, 3 × 10 6 c.f.u./ml for LXPBSN and 2 × 10 6 c.f.u./ml for LXPCSN. The difference of virus titers might be due to either different expression levels of neo marker or the cytotoxic effect of the transgene, or both.
Gene-specific correction of DNA repair defect To examine whether the transferred XPA, XPB and XPC correct the DNA repair defect of cells of the three XP 
Figure 2 UV survival curves in untransduced and transduced XP groups A, B and C cells. (--) MRC5V1 (a and c) and 198VI (b and d) wildtype cells; (-ć-) XP12ROSV (a), XP24VI (b), XPCS2BASV (c) and

XP16VI (d) untransduced and (-b-) transduced cells with LXPASN, LXPBSN and LXPCSN, respectively; (-̅-) untransduced and (-̆-) linker for insertion of DNA repair cDNAs: XPA, XPB and XPC; SV40: simian virus 40 early promoter; NEO: neomycin phosphotransferase gene. transduced XP30VI cells with LXPCSN (d); (----) cells transduced with LXPCSN (a and c) and LXPBSN (d, for XP30VI cells only). Arrows show transcription initiation orientation.
Figure 3 Unscheduled DNA synthesis of transduced and untransduced XP-A (a and b), XP-B/CS (c) and XP-C (d) cells.
UV doses (Ͻ2 grains per nucleus). However, an 87% of repair synthesis (46. 
Discussion
In previous reports we described the first retrovirus carrying a DNA repair gene (LXPDSN) which efficiently transduces diploid fibroblasts from DNA repair-deficient patients belonging to the XP-D group. 28, 29 This first result allowed us to envisage a novel gene therapy for skin cancers in XP patients. However, unlike other monogenic human disorders, several genes are involved in XP. They encode for the multi-protein complex which, in normal individuals, removes DNA damage and prevents deleterious consequences of UV radiation (skin cancers and other pathologies, including neurological degenerations). This heterogeneity of symptoms in XP patients reflects the genetic heterogeneity of the disease. In fact, severe neurological degenerations are often accompanied by skin tumors in patients belonging to XP-A and XP-D groups, and other metabolic dysfunctions typical of CS This implies that some DNA repair gene products play a role not only in the mere NER, but also in other pathways involved in cell differentiation and in development. HinfI restriction site generated by a T→C transition at Therefore, we developed retroviral vectors carrying position 62 (Figure 6a ), yielding F99S substitution in XPB additional DNA repair genes with the aims: (1) to valiprotein, which is present in only one allele. 35 HinfI cleavdate the novel transduction technology for other genes age produces two smaller fragments of the expected size involved in XP; and (2) among them, to transduce cells of 185 and 148 bp (Figure 6a ) only in untransduced from individuals belonging to the XP-A and XP-C XPCS2BASV cells (Figure 6b, lane 4 ). An identical pattern groups, which are the most representative in the XP of 185 bp fragments was observed in MRC5V1 and in patient population (27 and 26%, respectively). 36 Furthermore, unlike most XP-A, XP-B and XP-D patients, XP-C individuals suffer only from skin tumors (without the above mentioned complex clinical features) and, thus, they are the most probable candidates for gene therapy protocol.
The precise role of each DNA repair protein has not yet been established. However, biochemical data of purified proteins and/or amino acid (aa) sequence data allowed us to suggest a specific role in the NER pathway for each protein.
XPA XPA protein is a zinc metalloprotein consisting of 273 amino acids which, in connection with XPE protein, binds preferentially to UV-or chemical carcinogeninduced damaged DNA, and, synergically with other proteins (belonging to the TFIIH factor), drives other proteins of the complex toward the lesions and allows excision of damaged DNA strands. This suggests that it is involved in the recognition step of several types of DNA damage. [37] [38] [39] According to previous results, showing a reduced amount of XPA mRNAs and protein, [40] [41] [42] 
Figure 6 Restriction analysis of RT-PCR amplified fragment of
XP12ROSV cells exhibited no detectable XPA protein,
XPB/ERCC3 exon 3. (a) Diagrams showing HinfI sites in wild-type and XPCS2BASV cells and the expected size (bp) of the fragments generated.
when revealed by Western blot with anti-XPA antiserum.
Between the two diagrams the nucleotide sequence flanking the T→C tran-
The chain termination mutation at codon 207 generally XP24VI cells, where a similar chain elongation mutation is also present in exon 4 (K Tanaka, personal expression of XPC protein to normal levels in our XP-C cell lines. Therefore, this biochemical feature is consistent communication). This suggests that this portion of the gene is essential for the stability of XPA gene products, with the clinical features of XP-C patients, since XP patients with neurological abnormalities are generally either at mRNA or protein level, or both. However, following transduction with the recombinant LXPASN found in groups A, B and D, but not in group C. retrovirus, XPA protein could be easily detected by Western blot in XP12ROSV cell extract (Figure 5a ). Therefore,
Materials and methods
the restoration of XPA protein expression is sufficient to correct UV sensitivity and DNA repair to normal levels Clinical and genetical data of patients in both cells.
XP donors are listed in Table 1 . The XP12RO and the XP24VI patients have skin and neurological abnormali-XPB ties and both cell lines exhibited UV hypersensitivity. XPB protein is an 89 kDa species belonging to the TFIIH Patient XP12RO carries a C→T transition at nucleotide complex and it possesses a 3′-5′ ATP-dependent helicase 619 of exon 5 in the XPA gene. This mutation alters the activity. In connection with the 5′-3′ helicase activity of Arg-207 codon (CGA) to a nonsense codon (TGA) in both XPD protein, it releases DNA damaged strand after excialleles. 48 XP24VI was assigned to the XP-A group by sion. 43 It is required for the transcriptional activity of somatic fusion and microinjection experiments. The TFIIH complex. Therefore, it plays a dual role in both XP24VI patient came from a consanguinous marriage and NER and transcription. Only three families belong to the presented photosensitivity from 5 months after birth, and XP-B group: two presenting a combination of XP and CS was diagnosed as XP at the age of 5 years with an appar-(XP11BE and XPCSBA) and one presenting mild sympent facial dysmorphosis and difficulty in walking. Howtoms of TTD. Although the precise role of causative ever, no cutaneous tumor was found at the time of diagmutations in patients has not yet been established, differnosis. XPCS2BASV cell line came from one of two ent mutations, such as phenylalanine-to-serine (F99S) and brothers with relatively mild clinical symptoms of comthreonine-to-proline (T119S) substitutions, lead to differbined XP and CS and with a virtually complete deficiency ent cellular phenotypes (in terms of DNA repair) and of NER. This line was assigned to the XP-B group by clinical symptoms in patients, ie XP/CS combination and microinjection experiments. The sequence analysis on TTD, respectively. 35, 44 Our results showed a high sensi-PCR-amplified mRNA revealed a single base substitution tivity of XPCS2BASV cells to the cytotoxic effect of UV (T→C transition), resulting in a phenylalanine-to-serine in colony-forming assays, and a poor level of residual substitution at position 99 (F99S), and this mutation was UDS (Ͻ1% of normal), indicating that the F99S mutation found in only one allele. 35 The XP30VI patient was diagcauses virtually complete inactivation of the DNA repair nosed as classical XP at the age of 2 years without tumor function of the XPB protein. Furthermore, Western blots and the XP16VI patient was diagnosed at the age of 7 showed a reduced amount of 89 kDa polypeptide ( Figure  years with multiple facial carcinoma. Both were con5b), according to the hypothesis that in XPCS2BA only firmed as XP complementation group C by cell fusion the paternal allele is expressed. 35 Nevertheless, the experiments. reduced level of ERCC3 transcript could also be explained by alteration of the expression of ERCC3/XPB Cell culture conditions by the mutation. Transduction with LXPBSN confers, Cells were grown at 37°C in 5% CO 2 humidified atmoshowever, wild-type expression level of the protein and phere in Eagle's minimal essential medium (GIBCO, only wild-type mRNA species are expressed (Figure 5b) , Inchinnan, UK) supplemented with 15% fetal calf serum suggesting that dominant expression of the transgene (Dominique Dutscher, Strasbourg, France) and antibiotics over the endogenous mutant one occurs.
at 1 g/ml each of penicillin and streptomycin and 2.5 g/ml of fungizone (GIBCO), while 10% FCS was used XPC for transformed cells. NIH3T3 and retrovirus packaging The XPC protein is a 125 kDa polypeptide 45 and its ⌿CRE and ⌿CRIP cells were grown at 37°C in 10% CO 2 activity is supposed to drive repair proteins to damage in DMEM medium supplemented with fetal bovine DNA in nontranscribed strands, since XP-C cells display serum and antibiotics. defective repair of lesions localized only in nontranscribed strands. Furthermore, mutations in the p53 gene in skin tumors from these patients were detected only in Construction of vectors and production of recombinant retrovirus nontranscribed strands. 46 All mutations in the XPC gene (single aa substitutions, insertion or chain terminating)
The retroviral LXSN vector is based on MoMLV. 31, 32 Figure 1 depicts LXSN containing a selectable neomycin (Gidentified in several XP-C individuals, were accompanied by a many-fold reduction of XPC mRNA levels. 47 In 418) marker which is under the control of the SV40 early promoter. XPA and XPB genes are the fragments of 0.91 XP30VI and XP16VI cells used here, the low UV survival rate and reduced UDS levels (Figures 2d and 3d) are also kb and 2.85 kb full-length cDNA, respectively. 49,50 XPC gene is a fragment of 3.55 kb full-length cDNA. 45 These accompanied by undetectable XPC protein by Western blots (Figure 5c ). Although mutations in our cell lines are genes were inserted into appropriate restriction sites in LXSN polylinker. for primary and and then the cells were transfected with 5 g of DNA of each of the three recombinant plasmids using the stantransformed cells, respectively). Irradiation was performed as in UDS experiments and cells were maintained dard calcium phosphate method. When the cells reached confluency, the culture supernatant was harvested, filin medium supplemented with 20% and 10% FCS for primary and transformed fibroblasts, respectively, for 14 tered and used to transduce the ⌿CRIP cell line in the presence of polybrene (Sigma-Aldrich Chimie, St Quentin days. The relative survival was calculated as the number of colonies obtained in UV irradiated over unirradiated Fallavier, France) at 8 g/ml. ⌿CRIP cell line was cultured in the presence of neomycin (GIBCO) at 1 mg/ml cells. for selection and neo-resistant clones obtained were tested for retrovirus titer by transducing NIH3T3 fibro-
Detection of gene expression (Western blot)
The proteins encoded by the introduced genes were anablasts under neomycin selection (1 mg/ml). For every recombinant retrovirus at least 15 G418-resistant colonies lyzed by 6 or 8% (according to the molecular mass of proteins to be analyzed) acrylamide-SDS gel electrowere expanded and their titers were determined. These titers may vary from 10 3 to 10 6 c.f.u./ml according to the phoresis of cellular extracts obtained from different cell lines. Protein samples were transferred into Hybond + different genes cloned and, for the same construction, to different individual clones. Clones producing the retromembranes (Amersham, Les Ulis, France) and probed with specific antibodies, according to the manufacturer's virus with higher titers were expanded. Primary fibroblasts and transformed cells were transduced with the procedure: anti-XPA antiserum (kindly provided by Dr K Tanaka, IMCB, Osaka University, Japan); the monoclonal recombinant retrovirus according to the genetic complementation groups and were selected with 1 mg/ml of anti-XPB antibody (1B3) raised against the N-terminal of human XPB protein (AA 80-480) was a gift from Dr Jneomycin and grown in the presence of neomycin for at least 8 weeks.
M Egly (Strasbourg, France); and the polyclonal antibody raised against human XPC protein was kindly provided by Dr F Hanaoka (IMCB, Osaka University, Japan). UDS and RRS Analysis of repair synthesis was carried out in untransduced and transduced primary and transformed fibroReverse transcription PCR amplification Total RNA was isolated from approximately 1 × 10 8 cells blasts as previously described. 51 Briefly, cells were grown on glass coverslips for 2 days. After 2 more days in from MRC5V1 (normal), XPCS2BASV (XP-B/CS) and XPCS2BASV transduced by recombinant retrovirus serum-deprived medium (0.5%) they were UV irradiated with doses from 0 to 15 J/m 2 and then incubated with LXPBSN, using the RNA Isolation Kit (Bioprobe Systems, Montreuil-sous-Bois, France). RNA (5 g) was used for 3 H-thymidine at 10 Ci/ml (specific activity of 50 Ci/mmol; DuPont de Nemors, Les Ulis, France) for 3 h, reverse transcription reaction. Briefly, RNA was dissolved in 10 l of reverse transcriptase buffer (250 mm followed by a chase of 1 h with cold thymidine. Coverslips with the cells were mounted on to glass slides, Tris-HCl (pH 8.3), 375 mm KCl, 15 mm MgCl 2 ), in the presence of RNase inhibitor (Boehringer Mannheim, dipped in Kodak NTB-2 emulsion (Kodak, New York, NY, USA), and exposed for 1 week at 4°C. The mean Meylan, France), 5 l of 0.1 m DTT, 5 l of 10 mm dNTP, 1 g of poly-dT and 400 units of MoMLV reverse trannumber of grains per nucleus was obtained by counting at least 30 non-S-phase nuclei. RRS was measured as folscriptase (GIBCO) were added, and then incubated at 37°C for 30 min. PCR was performed to amplify the fraglows: cells were grown as for UDS experiments and UV irradiated with 15 J/m 2 . Cells were then incubated for 23 ment from position 22 to 225 in exon 3 of XPB/ERCC3 containing the T→C transition ( Figure 6a ) using primers: h and then labeled for 1 h in a medium containing 3 Huridine at 10 Ci/ml (specific activity of 50 Ci/mmol).
5′-TTGGAAGCCTTCTCTCCAG TTTACAAATATGC-3′ and 5′-GCATAATTCCATCAGGGACTCCAGTCTTG-3′ Autoradiography was performed as described above for measurement of UDS except that the exposure time was (GENSET, Paris, France). To 1 g of cDNA, PCR reaction contained 10 l of Taq reaction buffer (100 mm Tris-HCl, 24 h. pH 8.8, 15 mm MgCl2, 500 mm KCl, 1% Triton X-100), 1 l (1 pmole/l) of each primer, 10 l of dNTPs (2 mm), UV survival The colony-forming ability was determined in primary and 1. 
